Evidence map›Paper›PMID 36451069›Full record

ArticlePharmaceutical research2023

What Do We Know About the Smallpox Virus? A Journey Between Clinic and Therapy.

Andrea Zovi, Francesco Ferrara, Sarah Sorrentino, Roberto Langella, Ugo Trama, Mariarosaria Boccellino, Antonio Vitiello

Abstract read
In one paragraph

Article in Pharmaceutical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Andrea ZoviMinistry of Health, Viale Giorgio Ribotta 5, 00144, Rome, Italy.ORCID https://orcid.org/0000-0002-6528-2171
Francesco FerraraPharmaceutical Department, Asl Napoli 3 Sud, Dell'amicizia street 22, 80035, Nola, Naples, Italy. f.ferrara@aslnapoli3sud.it.ORCID http://orcid.org/0000-0001-9298-6783
Sarah SorrentinoPharmaceutical Department, Asl Napoli 3 Sud, Dell'amicizia street 22, 80035, Nola, Naples, Italy.
Roberto LangellaItalian Society of Hospital Pharmacy (SIFO), SIFO Secretariat of the Lombardy Region, Via Carlo Farini, 81, 20159, Milan, Italy.
Ugo TramaHealth Protection and Coordination of the Campania Regional Health System, Naples, Italy.
Mariarosaria BoccellinoDepartment of Biochemistry, Biophysics and General Pathology, University of Campania "Luigi Vanvitelli", Naples, Italy.
Antonio VitielloClinical pharmacologist, Ministry of Health, Viale Giorgio Ribotta 5, 00144, Rome, Italy.ORCID https://orcid.org/0000-0003-2623-166X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeModern research is increasingly focusing on the study of new viruses and the re-emergence of past microbes, such as Coronaviruses, particularly Sars-Cov2 that was responsible for the very recent pandemic. METHODS AND

resultsThis infection manifested itself and still continues to manifest as a severe respiratory syndrome. The main discriminator of whether or not one succeeds in overcoming this infection may depend on a great many factors, but the main one is definitely determined by vaccination, which has minimized hospitalizations and more severe syndromes.

conclusionRecently, a new virus, the monkeypox virus, which was previously confined to Central and West Africa but is now gradually spreading to more than 30 countries including the United States of America, where such an infection is not endemic, is coming forward again.

Indexed as

COVID-19Mpox, MonkeypoxVariola virusHumansRNA, ViralSARS-CoV-2United StatesRNA, Viralepidemiologyinfectiousmonkeypoxsmallpoxvaccinevirology

Identifiers

PMID36451069
PMCPMC9713125

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.